Correlation between Salivary Oxidative Stress Biomarkers and Clinical Severity of Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients

Abstract

Objective

Radiation-induced oral mucositis (RIOM) is the most common side effect of radiotherapy (RT) in head and neck cancer (HNC) patients. Oxidative stress plays a major role in the multistep pathogenesis of RIOM. However, the current understanding of the relationship between salivary biomarkers of oxidative stress and the clinical severity of RIOM remains limited. This study aims to analyze the correlation between salivary oxidative stress biomarkers and the clinical severity of RIOM.

Materials and Methods

This cross-sectional study analyzed the levels of salivary oxidative stress biomarkers from 25 HNC patients who underwent RT using enzyme-linked immunosorbent assay and the clinical grades of RIOM in the cohort. The data were then analyzed using the Spearman's correlation statistical test (p-value < 0.05).

Results

The findings demonstrated a significant correlation between salivary glutathione levels (r: –0.396; p: 0.050), superoxide dismutase levels (r: –0.447; p: 0.025), malondialdehyde levels (r: 0.479; p: 0.015), and lactate dehydrogenase levels (r: 0.460; p: 0.025) with the clinical severity of RIOM.

Conclusion

The higher salivary oxidative stress correlates with higher severity of RIOM.

Keywords

glutathione - superoxide dismutase - malondialdehyde - lactate dehydrogenase - oral mucositis - saliva - head and neck cancer - radiotherapy

• References

• 1 Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
• 2 Liu S, Zhao Q, Zheng Z. et al. Status of treatment and prophylaxis for radiation-induced oral mucositis in patients with head and neck cancer. Front Oncol 2021; 11: 642575
• 3 Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2007; 68 (04) 1110-1120
• 4 World Health Organization, ed. WHO Handbook for Reporting Results of Cancer Treatment. Geneva. Albany, NY: World Health Organization; sold by WHO Publications Centre USA; 1979: 45 (WHO offset publication; no. 48)
• 5 Lodi G, Varoni E, Robledo-Sierra J, Villa A, Jontell M. Oral ulcerative lesions. In: Contemporary Oral Medicine: A Comprehensive Approach to Clinical Practice [Internet]. 1st ed.. 2019: 1010-1011 . Accessed April 26, 2025 at: https://doi.org/10.1007/978-3-319-72303-7
• 6 Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol 2017; 7: 89
• 7 Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006; 106 (02) 329-336
• 8 Sonis ST. The Pathobiology of Oral Mucositis. In: Oral Mucositis [Internet]. Tarporley: Springer Healthcare Ltd.; 2012: 7-13 . Accessed July 17, 2024 at: http://link.springer.com/10.1007/978-1-907673-46-7_2
• 9 Nguyen H, Sangha S, Pan M. et al. Oxidative stress and chemoradiation-induced oral mucositis: a scoping review of in vitro, in vivo and clinical studies. Int J Mol Sci 2022; 23 (09) 4863
• 10 Mohammed AI, Sangha S, Nguyen H. et al. Assessment of oxidative stress-induced oral epithelial toxicity. Biomolecules 2023; 13 (08) 1239
• 11 Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014; 2014: 360438
• 12 Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alex J Med 2018; 54 (04) 287-293
• 13 Strycharz-Dudziak M, Kiełczykowska M, Drop B. et al. Total antioxidant status (TAS), superoxide dismutase (SOD), and glutathione peroxidase (GPx) in oropharyngeal cancer associated with EBV infection. Oxid Med Cell Longev 2019; 2019: 5832410
• 14 Iovoli AJ, Turecki L, Qiu ML. et al. Severe oral mucositis after intensity-modulated radiation therapy for head and neck cancer. JAMA Netw Open 2023; 6 (10) e2337265
• 15 Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis 2006; 12 (03) 229-241
• 16 Lee CT, Galloway TJ. Pathogenesis and amelioration of radiation-induced oral mucositis. Curr Treat Options Oncol 2022; 23 (03) 311-324
• 17 Khoubnasabjafari M, Ansarin K, Jouyban A. Salivary malondialdehyde as an oxidative stress biomarker in oral and systemic diseases. J Dent Res Dent Clin Dent Prospect 2016; 10 (02) 71-74
• 18 Firdausa AY, Ahimsa SS, Ahmada RA. et al. Malondialdehyde level and tissue apoptosis count as an early-detection marker of oral potentially malignant disorders. Eur J Dent 2023; 17 (01) 155-160
• 19 Jayachander D, Shivashankara A, Vidyasagar M. et al. Salivary parameters as predictive markers for radiation-induced treatment response in head and neck cancers: an investigational study. Middle East J Cancer 2018; 9 (02) 133-142
• 20 Wu H, Wang Y, Ying M, Jin C, Li J, Hu X. Lactate dehydrogenases amplify reactive oxygen species in cancer cells in response to oxidative stimuli. Signal Transduct Target Ther 2021; 6 (01) 242
• 21 Mohajertehran F, Ayatollahi H, Jafarian AH. et al. Overexpression of lactate dehydrogenase in the saliva and tissues of patients with head and neck squamous cell carcinoma. Rep Biochem Mol Biol 2019; 7 (02) 142-149
• 22 Gholizadeh N, Alipanahi Ramandi M, Motiee-Langroudi M, Jafari M, Sharouny H, Sheykhbahaei N. Serum and salivary levels of lactate dehydrogenase in oral squamous cell carcinoma, oral lichen planus and oral lichenoid reaction. BMC Oral Health 2020; 20 (01) 314
• 23 Derindağ G, Akgül HM, Kızıltunç A, Özkan Hİ, Kızıltunç Özmen H, Akgül N. Evaluation of saliva glutathione, glutathione peroxidase, and malondialdehyde levels in head-neck radiotherapy patients. Turk J Med Sci 2021; 51 (02) 644-649
• 24 Rhomdhoni AC, Kurniawan P, Hidayati T. Correlation between superoxide dismutase serum level alteration with neck metastatic tumor post cisplatin-paclitaxel chemotherapy response in nasopharyngeal carcinoma patients. Indian J Otolaryngol Head Neck Surg 2019; 71 (Suppl. 01) 643-646
• 25 Toorang F, Seyyedsalehi MS, Sasanfar B. et al. Dietary total antioxidant capacity and head and neck cancer: a large case-control study in Iran. Front Nutr 2023; 10: 1226446
• 26 Traktama DO, Sufiawati I. Oral mucositis severity in patient with head and neck cancer undergoing chemotherapy and/or radiotherapy. Majalah Kedokteran Gigi Indonesia 2018; 4 (01) 52
• 27 Kusiak A, Jereczek-Fossa BA, Cichońska D, Alterio D. Oncological-therapy related oral mucositis as an interdisciplinary problem—literature review. Int J Environ Res Public Health 2020; 17 (07) 2464
• 28 Colevas AD, Yom SS, Pfister DG. et al. ‘NCCN guidelines ® insights: head and neck cancers, version 1.2018 featured updates to the NCCN guidelines’. J Natl Compr Canc Netw 2018; 16 (05) 479-490
• 29 Bell A, Kasi A. Oral mucositis. StatPearls – NCBI Bookshelf 2023; 12 (03) 229-241